Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_assertion type Assertion NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_head.
- NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_assertion wasGeneratedBy ECO_0000203 NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_provenance.
- NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_assertion wasDerivedFrom befree-2016 NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_provenance.
- NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_assertion SIO_000772 24520174 NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_provenance.
- NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_assertion evidence source_evidence_literature NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_provenance.
- NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_assertion description "[Thus, indolent human glioma cells deficient for TF remain viable but permanently dormant at the injection site for nearly a year, whereas the expression of TF leads to a step-wise transition to latent and overt tumor growth phases, a process that is preceded by recruitment of vascular (CD105(+)) and myeloid (CD11b(+) and F4/80(+)) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1154507.RAXtzMRis82WQiW_hps79c7is7W5pYeahmbJ2kw9Z_KIo130_provenance.